Advertisement
Screener

AGENUS INC (AGEN) Material Contracts, 2018

AGENUS INC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2018-11-07: Form 10-Q; Exhibit 10.3; Description Consulting Agreement dated July 12, 2018, by and between Agenus Inc. and Karen Valentine. Filed herewith..
  • 2018-11-07: Form 10-Q; Exhibit 10.2; Description Consulting Agreement, effective July 1, 2018, as amended, by and between AgenTus Therapeutics, Inc. and Dr. Robert Stein. Filed herewith..
  • 2018-11-07: Form 10-Q; Exhibit 10.1; Description Amendment No.1 to Consulting Agreement, effective July 1, 2018, by and between Agenus Inc. and Dr. Robert Stein. Filed herewith..
  • 2018-10-11: Form 8-K; Exhibit 10.1; Description Stock Purchase Agreement, dated October 10, 2018, between the Company and the purchasers listed on Exhibit A thereto..
FiledFormExhibitDescription
2018-11-0710-Q10.3Consulting Agreement dated July 12, 2018, by and between Agenus Inc. and Karen Valentine. Filed herewith.
2018-11-0710-Q10.2Consulting Agreement, effective July 1, 2018, as amended, by and between AgenTus Therapeutics, Inc. and Dr. Robert Stein. Filed herewith.
2018-11-0710-Q10.1Amendment No.1 to Consulting Agreement, effective July 1, 2018, by and between Agenus Inc. and Dr. Robert Stein. Filed herewith.
2018-10-118-K10.1Stock Purchase Agreement, dated October 10, 2018, between the Company and the purchasers listed on Exhibit A thereto.
2018-05-1010-Q10.3Separation Agreement dated December 19, 2017, by and between Agenus Inc. and Jean-Marie Cuillerot. Filed herewith.
2018-05-1010-Q10.2Change of Control Agreement dated February 1, 2016, by and between Agenus Inc. and Alex Duncan. Filed herewith.
2018-05-1010-Q10.1Contract of Employment dated February 1, 2016, by and between Agenus UK Limited and Alex Duncan. Filed herewith.

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60